Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Do | Venus Concept signals modest margin impact from tariffs and targets next-gen body device launch in H2 2025 amid challenging capital environment | 1 | Seeking Alpha | ||
Do | Venus Concept Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
Do | Venus Concept GAAP EPS of -$17.44, revenue of $13.64M | 2 | Seeking Alpha | ||
Do | Venus Concept Inc. - 8-K, Current Report | 1 | SEC Filings | ||
VENUS CONCEPT Aktie jetzt für 0€ handeln | |||||
Do | Venus Concept Inc.: Venus Concept Announces First Quarter 2025 Financial Results | 38 | GlobeNewswire (Europe) | TORONTO, May 15, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three... ► Artikel lesen | |
02.05. | Venus Concept Inc. - 8-K, Current Report | 2 | SEC Filings | ||
14.04. | Venus Concept schließt Aktienangebot über 1,57 Mio. US-Dollar ab | 6 | Investing.com Deutsch | ||
14.04. | Venus Concept Inc.: Venus Concept Raises a Total of Approximately $2.7 Million in Gross Proceeds from Previously Announced Registered Direct Offerings of Common Stock | 52 | GlobeNewswire (Europe) | TORONTO, April 14, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, today announced the closing of its previously... ► Artikel lesen | |
11.04. | Venus Concept kündigt Aktienemission im Wert von 1,5 Millionen US-Dollar an | 1 | Investing.com Deutsch | ||
11.04. | Venus Concept announces $1.5 million stock offering | 1 | Investing.com | ||
11.04. | Venus Concept Inc.: Venus Concept Announces $1.5 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules | 4 | GlobeNewswire (USA) | ||
10.04. | Venus Concept Inc.: Venus Concept Announces Closing of $1.1 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules | 3 | GlobeNewswire (USA) | ||
10.04. | Pre-market Movers: InnovAge, Venus Concept, Pasithea Therapeutics, Full House Resorts, Antelope Enterprise | 508 | AFX News | OTTAWA (dpa-AFX) - The following are some of the stocks making big moves in Thursday's pre-market trading (as of 09.05 A.M. ET).In the Green InnovAge Holding Corp (INNV) is up over 58% at $4.45.
Pasithea... ► Artikel lesen | |
09.04. | Venus Concept announces $1.1 million stock sale | 2 | Investing.com | ||
09.04. | Venus Concept kündigt Aktienverkauf im Wert von 1,1 Millionen US-Dollar an | 1 | Investing.com Deutsch | ||
09.04. | Venus Concept Inc.: Venus Concept Announces $1.1 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules | 1 | GlobeNewswire (USA) | ||
09.04. | Venus Concept Stock Soars Nearly 198% | 1 | RTTNews | ||
09.04. | Pre-market Movers: Venus Concept, Scworx, Greenfire Resources, Alta Equipment Group, Qualigen Therapeutics | 471 | AFX News | OTTAWA (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 07.25 A.M. ET).In the Green Venus Concept Inc (VERO) is up over 310% at $11.82.
Scworx... ► Artikel lesen | |
09.04. | Why Venus Concept Shares Are Trading Higher By Over 200%; Here Are 20 Stocks Moving Premarket | 3 | Benzinga.com | ||
08.04. | Venus Concept Inc. - 8-K, Current Report | 4 | SEC Filings |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
ECKERT & ZIEGLER | 63,25 | +1,28 % | EQS-News: Eckert & Ziegler SE: Eckert & Ziegler startet mit Ergebniswachstum in Q1 2025 und bestätigt Jahresprognose | EQS-News: Eckert & Ziegler SE
/ Schlagwort(e): Quartalsergebnis
Eckert & Ziegler startet mit Ergebniswachstum in Q1 2025 und bestätigt Jahresprognose
13.05.2025 / 07:45... ► Artikel lesen | |
UNITEDHEALTH | 245,05 | -11,15 % | UnitedHealth Group-Aktie leicht im Minus (338,6583 €) | Im US-amerikanischen Wertpapierhandel liegt die Aktie der UnitedHealth Group gegenwärtig im Minus. Die Aktie notiert derzeit bei 381,59 US-Dollar. Die UnitedHealth Group-Aktie verzeichnet aktuell ein... ► Artikel lesen | |
TELADOC HEALTH | 6,470 | -1,63 % | Teladoc Health, Inc. (TDOC): Among the Best Growth Stocks Under $10 to Buy Right Now | ||
THERMO FISHER | 361,85 | -0,44 % | Cybin taps Thermo Fisher for potential commercial manufacturing of CYB003 | ||
ROKU | 62,80 | -2,41 % | Roku Analyst Says TV's Future Hinges On This 'Powerful' Cost Saver, But It's Still Early | ||
BICO GROUP | 3,188 | -7,00 % | Bico Group Aktie: BRUTALE PROGNOSE zwingt Anleger zum Handeln. So sollten Sie HEUTE reagieren! | ||
SERNOVA BIOTHERAPEUTICS | 0,129 | -5,15 % | Sernova Biotherapeutics Inc: Sernova talks interim data from Cell Pouch trial | ||
PLUS THERAPEUTICS | 0,505 | 0,00 % | Plus Therapeutics Inc.: Plus Therapeutics' REYOBIQ Shows Clinical Benefit and Safety in the ReSPECT-LM Clinical Trial for Patients with Leptomeningeal Metastases (LM) | Multiple long-term LM survivors in those patients receiving multiple doses of REYOBIQ RNA sequencing data show early tumor apoptosis and activation of innate immune responses Updated ReSPECT data... ► Artikel lesen | |
RESMED | 222,50 | +0,63 % | Dividendenbekanntmachungen (08.05.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADDNODE GROUP AB SE0017885767 1,15 SEK 0,1052 EUR AG BARR PLC GB00B6XZKY75 0,1376 GBP 0,1617 EUR ALANTRA PARTNERS SA ES0126501131 - 0... ► Artikel lesen | |
HENRY SCHEIN | 62,36 | -0,61 % | Aktie von Henry Schein: Kurs mit wenig Bewegung (62,7623 €) | Die Wertschätzung für das Wertpapier von Henry Schein hat sich an der Börse heute kaum geändert. Die Aktie kostete zuletzt 70,15 US-Dollar. Kaum auffällig ist aktuell am Aktienmarkt der Kurs von Henry... ► Artikel lesen | |
ATOSSA THERAPEUTICS | 0,905 | +16,32 % | Atossa Therapeutics Inc: Atossa Therapeutics Announces Full Results from I-SPY 2 Endocrine-Optimization Sub-Study Evaluating Low-Dose (Z)-Endoxifen | Feasibility endpoint achieved; rapid Ki-67 suppression and substantial MRI-confirmed tumor shrinkage observed with favorable safety profile
SEATTLE, May 14, 2025 /PRNewswire/ -- Atossa Therapeutics... ► Artikel lesen | |
PING AN HEALTHCARE | 0,802 | -5,62 % | Ping An Healthcare and Technology Company Limited: Ping An Health Reports 25.8% Year-on-Year Revenue Growth in Q1 2025, with Profitability Accelerating | Revenue and Profit Surge, Driven by "AI + Health Care" Value Empowerment
SHANGHAI and HONG KONG, April 24, 2025 /PRNewswire/ -- Ping An Healthcare and Technology... ► Artikel lesen | |
EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Reports First Quarter 2025 Financial Results and Provides Business Update | SAN DIEGO, May 15, 2025 /PRNewswire/ -- Women's health innovator Evofem Biosciences, Inc. (OTCPK: EVFM), today announced financial results for the first quarter... ► Artikel lesen | |
FRESENIUS | 42,520 | +1,80 % | BERENBERG stuft Fresenius SE auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Fresenius von 45 auf 50 Euro angehoben und die Einstufung auf "Buy" belassen. Nach dem starken Jahresstart der Aktie hätten... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 48,850 | +1,45 % | GOLDMAN SACHS stuft Siemens Healthineers auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat das Kursziel für Siemens Healthineers von 60 auf 56 Euro gesenkt, aber die Einstufung auf "Neutral" belassen. Richard Felton passte... ► Artikel lesen |